Skip to search boxSkip to navigationSkip to main content

Innovative cancer treatments that augment radiotherapy or chemotherapy by the use of immunotherapy or gene therapy

*Corresponding author for this work
  • IMC University of Applied Sciences Krems
    ,
  • Tel Aviv University
Scholary Output:
Contribution to journal
Review article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Cancer is a complex multifactorial disease requiring combinations of several therapeutic modalities to treat it effectively. Despite advances in the field of prevention and treatment of cancer, morbidity and mortality remain high, especially for tumors that cannot be completely removed, as well as for those that are highly recurrent or highly metastatic. Surgery, radiotherapy and chemotherapy, alone or in combination, are currently the prevalent treatment modalities. Yet, in order to treat metastases more effectively, the immune response must be recruited. In this review, we will focus on recent patents in the field of cancer that have concentrated on combining chemotherapy or radiotherapy strategies with immunotherapy, in order to eradicate the primary tumor as well as its metastases.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 201-208 (8 pages)

Journal (Volume, Issue Number)

Recent Patents on Anti-Cancer Drug Discovery (Volume 1, Issue 2)

Publication milestones

  • Published - 2006

Publication status

Published - 2006

ISSN

1574-8928

Publication IDs

  • Scopus: 39049113003
  • PubMed: 18221037

Publication metrics

Metrics

Scopus
citations
SciVal
FWCI
0.07
SciVal
Author count
2
SciVal
citations
3
SciVal
Paper percentile
44
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
3
Captures
11